Xylem (XYL) Misses Q3 EPS by 1c, Updates FY Guidance

Xylem (NYSE: XYL) reported Q3 EPS of $0.77, $0.01 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.3 billion.

GUIDANCE:

Xylem sees FY2018 EPS of $2.87-$2.89, versus the consensus of $2.90. Xylem sees FY2018 revenue of $5.2 billion, versus the consensus of $5.21 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance